These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Konings J; Govers-Riemslag JW; Philippou H; Mutch NJ; Borissoff JI; Allan P; Mohan S; Tans G; Ten Cate H; Ariëns RA Blood; 2011 Oct; 118(14):3942-51. PubMed ID: 21828145 [TBL] [Abstract][Full Text] [Related]
12. High-Throughput Docking and Molecular Dynamics Simulations towards the Identification of Potential Inhibitors against Human Coagulation Factor XIIa. Xu D; Xue G; Peng B; Feng Z; Lu H; Gong L Comput Math Methods Med; 2020; 2020():2852051. PubMed ID: 32549905 [TBL] [Abstract][Full Text] [Related]
13. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood. Hansson KM; Nielsen S; Elg M; Deinum J J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753 [TBL] [Abstract][Full Text] [Related]
14. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition. Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation. Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760 [TBL] [Abstract][Full Text] [Related]
16. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release. Steen Burrell KA; Layzer J; Sullenger BA J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925 [TBL] [Abstract][Full Text] [Related]
17. Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals. Barbieri CM; Wang X; Wu W; Zhou X; Ogawa AM; O'Neill K; Chu D; Castriota G; Seiffert DA; Gutstein DE; Chen Z J Pharmacol Exp Ther; 2017 Mar; 360(3):466-475. PubMed ID: 28035006 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Some New 2,5-Substituted 1-Ethyl-1H-benzoimidazole Fluorinated Derivatives as Direct Thrombin Inhibitors. Li M; Ren Y Arch Pharm (Weinheim); 2015 May; 348(5):353-65. PubMed ID: 25824648 [TBL] [Abstract][Full Text] [Related]
19. Potent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming. Ford DJ; Duggan NM; Fry SE; Ripoll-Rozada J; Agten SM; Liu W; Corcilius L; Hackeng TM; van Oerle R; Spronk HMH; Ashhurst AS; Mini Sasi V; Kaczmarski JA; Jackson CJ; Pereira PJB; Passioura T; Suga H; Payne RJ J Med Chem; 2021 Jun; 64(11):7853-7876. PubMed ID: 34044534 [TBL] [Abstract][Full Text] [Related]
20. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities. Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]